These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1815059)

  • 1. Preparation and evaluation of Eudragit gels. II: In vitro release of salicylic acid, sodium salicylate, and ketoprofen from Eudragit L and S organogels.
    Kawata M; Suzuki T; Kim NS; Ito T; Kurita A; Miyagoe Y; Goto S
    J Pharm Sci; 1991 Nov; 80(11):1072-4. PubMed ID: 1815059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of Eudragit gels. I: Eudragit organogels containing drugs as rectal sustained-release preparations.
    Goto S; Kawata M; Suzuki T; Kim NS; Ito C
    J Pharm Sci; 1991 Oct; 80(10):958-61. PubMed ID: 1784005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of Eudragit type on the dissolution rate of acetylsalicylic acid from matrix tablets.
    Jovanović M; Jovicić G; Djurić Z; Agbaba D; Karljiković-Rajić K; Nikolić L; Radovanović J
    Acta Pharm Hung; 1997 Nov; 67(6):229-34. PubMed ID: 9423294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):305-16. PubMed ID: 3508191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of film properties to drug release from monolithic films containing adjuvants.
    Jenquin MR; Sarabia RE; Liebowitz SM; McGinity JW
    J Pharm Sci; 1992 Oct; 81(10):983-9. PubMed ID: 1432624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
    Khanfar MS; Salem MS; Najib NM; Pillai GK
    Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix.
    Mehta KA; Kislalioglu MS; Phuapradit W; Malick AW; Shah NH
    Int J Pharm; 2001 Feb; 213(1-2):7-12. PubMed ID: 11165089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
    Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
    J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
    Kibria G; Ul-Jalil R
    Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and chemical factors influencing the release of drugs from acrylic resin films.
    Jenquin MR; Liebowitz SM; Sarabia RE; McGinity JW
    J Pharm Sci; 1990 Sep; 79(9):811-6. PubMed ID: 2273466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the physical structure and the mechanism of drug release from an enteric matrix microspheres with a near-zero-order release kinetics using SEM and quantitative FTIR.
    Obeidat WM; Obeidat SM; Alzoubi NM
    AAPS PharmSciTech; 2009; 10(2):615-23. PubMed ID: 19444619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ultrasound-assisted compaction on Ketoprofen/Eudragit S100 mixtures.
    Sancin P; Caputo O; Cavallari C; Passerini N; Rodriguez L; Cini M; Fini A
    Eur J Pharm Sci; 1999 Feb; 7(3):207-13. PubMed ID: 9845807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid, theophylline, and benzoic acid.
    Serajuddin AT; Jarowski CI
    J Pharm Sci; 1985 Feb; 74(2):148-54. PubMed ID: 3989683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 13C solid state NMR to elucidate physico-chemical association in Eudragit RS100 microencapsulated acyl esters of salicylic acid.
    Vachon MG; Nairn JG
    Eur J Pharm Biopharm; 1998 Jan; 45(1):9-21. PubMed ID: 9689531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrylic polymers as thickening agents for tetraglycol cosolvent.
    Bonacucina G; Palmieri GF
    J Pharm Sci; 2006 Apr; 95(4):726-36. PubMed ID: 16435364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.